(Photo source: Freepik) Show Quick Read Summary is AI Generated. Newsroom Reviewed

Pharmaceutical company Corona Remedies raised Rs 194.85 crore from 15 institutional investors through its anchor book, ahead of its Rs 655-crore initial public offering opening on Monday.

The IPO is entirely an offer-for-sale with no fresh issue component. The offer, priced in the range of Rs 1,008–1,062 per share, will be open for subscription from Dec. 8 to 10. The company has allotted 18.34 lakh shares to anchor investors at the upper end of the price band.

According to the company’s exchange filing, 13.59 lakh shares worth Rs 144.4 crore were allotted to 11 domestic mutual funds — including SBI Mutual Fund, ICICI Prudential MF, Kotak Mahindra AMC, Axis Mutual Fund, Mirae Asset, Aditya Birla Sun L

See Full Page